The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 3,434 | 24,700 | SH | SOLE | 24,700 | 0 | 0 | ||
FGL HLDGS | ORD SHS | G3402M102 | 13,425 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
FGL HLDGS | *W EXP 11/30/202 | G3402M110 | 1,478 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
ISHARES TR | FLTG RATE NT ETF | 46429B655 | 24,503 | 480,254 | SH | SOLE | 480,254 | 0 | 0 | ||
MELINTA THERAPEUTICS INC | COM | 58549G100 | 65,601 | 16,607,959 | SH | SOLE | 16,607,959 | 0 | 0 | ||
SHIRE PLC | SPONSORED ADR | 82481R106 | 5,511 | 30,400 | SH | SOLE | 30,400 | 0 | 0 | ||
SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 365 | 182,395 | SH | SOLE | 182,395 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 2,068 | 41,700 | SH | SOLE | 41,700 | 0 | 0 |